(S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one acetate CAS: 1325209-27-5

Product Parameters
Catalog No. BK36R2
CAS.RN 1325209-27-5
Purity NLT 98%
Product Overview

(S)-3-(3-((4,5-dimethoxybicyclo[4.2.0]oct-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azapyro-2-one acetate is a structurally complex pharmaceutical intermediate primarily used in the synthesis and development of novel antitumor, antiviral, and central nervous system drugs. This compound exhibits high stereoselectivity, making it suitable for drug molecule skeleton construction and the introduction of key functional groups. It is widely used in small-scale preparation, pilot-scale amplification, and commercial production processes in the early stages of drug development, and is an important precursor for the synthesis of high-value-added drugs.

Applications
  • Drug molecular skeleton construction
  • Antitumor drug synthesis
  • Antiviral drug development
  • Central nervous system drug research
  • Custom synthesis of pharmaceutical intermediates
Quality & Supply Capability

English Name: (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one acetate Properties: This product is a white to off-white solid containing multiple methoxy and amino functional groups. It exhibits good chemical stability and is suitable for various organic synthesis reaction systems. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the specific COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging Document Support: COA, MSDS, HPLC, NMR, etc. Our company can provide a full-process service from laboratory samples to industrial batch production, covering small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust purity standards, impurity control schemes, packaging specifications, and delivery cycles according to customer needs, and provide complete quality documentation support. Meanwhile, we have a professional technical team that can provide customers with comprehensive technical support from process development and route optimization to project transformation, helping customers to efficiently advance the drug development process.

Why Choose Bioncan

Focused on pharmaceutical intermediates, possessing extensive synthesis experience and a professional team. Full-scale supply capability to meet diverse needs from laboratory to commercialization. Provides complete quality control documentation to ensure controllable and traceable product quality. Supports customized requirements, adjusting purity, impurity control, and packaging specifications according to customer specifications. Provides supporting process optimization and scale-up technologies to help customers achieve efficient commercialization.

Intermediates of Ivabradine hydrochloride
Catalog No. Product Name CAS
BA05GW Ivabradine hydrochloride API 148849-67-6
BK82Q4 4,5-Dimethoxy-1-cyanobenzocyclobutane 35202-54-1
BK598V (1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride 866783-13-3
BK33FJ 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one 73942-87-7
BK56VJ (S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)-N-methylmethanamine 866783-12-2
BK206L Dehydro ivabradine 1086026-31-4
BK4YJ2 N-(3-Bromopropyl)-Phthalimide 5460-29-7
BK3E8G 2,2-Dimethoxy acetaldehyde 51673-84-8
BK40K6 1,1-Diethoxyethene 2678-54-8
BK9D07 The metabolite of ivabradine 215935-23-2
BK752T 3,4-DimethoxyPhenylethylamine 120-20-7
BK364P C-(3,4-DIMETHOXY-BICYCLO[4.2.0]OCTA-1(6),2,4-TRIEN-7-YL)-METHYLAMINE 73344-75-9
BK96F9 (3,4-DiMethyoxy-bicyclo(4,2,0)octa-1(6),2,4-trien-7-ylMethyl)-carbaMic acid ethyl ester 148870-55-7
BK8YQ4 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one 148870-57-9
BK7CK9 Propanedioic acid, 2-​(2-​bromo-​4,​5-​dimethoxyphenyl)​-​, 1,​3-​dimethyl ester 1069115-30-5
BK1AT9 Bicyclo[4.2.0]​octa-​1,​3,​5-​triene-​7,​7-​dicarboxylic acid, 3,​4-​dimethoxy-​, 7,​7-​dimethyl ester 1069115-32-7
BK9Z16 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one hydrochloride 163629-94-5
BK813C 4,5-diMethoxy-N-Methyl-1,2-dihydrocyclobutabenzene-1-carboxaMide 1206230-27-4
BK2BU0 3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 148870-58-0
BK2PD7 3-(3-(((S)-4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one hydrochloride 1393427-01-4
BK5KH5 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1393427-02-5
BK45M1 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(2,2-dimethoxyethyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1393427-03-6
BK5EL6 (3,4-DiMethoxyphenyl)acetyl chloride 10313-60-7
BK8E10 7,8-Dimethoxy-3-(3-((2-(3,4-dimethoxyphenyl)acetyl)(methyl)amino)propyl)-2,3-dihydro-1H-benzo[d]azepin-2-one 1393427-04-7
BK2YU2 4,5-DIBROMOVERATROLE 37895-73-1
BK67FH (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1-oxide 1132079-01-6
BK2Z7N (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2-oxo-2,3-dihydro-1H-benzo[d]azepin-1-ium chloride 1246638-10-7
BK0F52 Bicyclo[4.2.0]​octa-​1,​3,​5-​triene-​7-​carboximidamide, 3,​4-​dimethoxy-​N-​methyl-​N-​[3-​(1,​2,​4,​5-​tetrahydro-​7,​8-​dimethoxy-​2-​oxo-​3H-​3-​benzazepin-​3-​yl)​propyl]​- 1246672-58-1
BK8Q64 7,8-Dimethoxy-3-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-2,3-dihydro-1H-benzo[d]azepin-2-one 98062-25-0
BK85JV 3-chloro-N-{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}-N-methyl-1-propanamine 1031767-71-1
BK5F84 (S)-N-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)-N-methyl-3-(7,8-dimethoxy-2-oxo-2,3-dihydro-1H-benzo[d]azepin-3-yl)propan-1-aminium chloride 1325209-22-0
BK515P (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one sulfate 1325209-23-1
BK5J56 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one mesylate 1325209-25-3
BK32MX (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one hydrobromide 1325209-24-2
BK1E79 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one phosphate 1325209-26-4
BK36R2 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one acetate 1325209-27-5
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 1325209-27-5, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.